Sponsored by:

Molecular Imaging: Page 299

Dilon promotes declipseSPECT study results
By AuntMinnie.com staff writers
Breast-specific gamma imaging developer Dilon Diagnostics is highlighting clinical research regarding its declipseSPECT device presented in March at the Society of Surgical Oncology annual cancer symposium.
May 8, 2012
DoE awards granted for Mo-99 production
By AuntMinnie.com staff writers
The Morgridge Institute for Research has received a $20.6 million award from the U.S. Department of Energy's (DoE) National Nuclear Security Administration to support the development of a new process and manufacturing plant for the isotope molybdenum-99 (Mo-99).
May 8, 2012
Oral antioxidants could prevent DNA damage from radiation
By Rosemary Frei
Canadian researchers plan to start clinical trials soon of an oral antioxidant cocktail designed to prevent radiation-induced DNA damage from medical imaging scans. The trial follows tests they've already conduct in humans -- more specifically, themselves.
May 6, 2012
ARRS: Unnecessary imaging tests follow oncologic PET/CT
By Wayne Forrest
Radiologists and nuclear medicine physicians recommended additional imaging tests about 30% of the time as a follow-up to oncologic PET/CT scans, with approximately half of those recommendations being unnecessary, according to a new study presented on Friday at the American Roentgen Ray Society (ARRS) meeting in Vancouver.
May 3, 2012
Lantheus adds to management team
By AuntMinnie.com staff writers
Lantheus Medical Imaging has added two new vice presidents to its management team.
May 3, 2012
Canada to fund brain research
By AuntMinnie.com staff writers
The Canadian government has unveiled plans to invest in neuroscience research with the creation of the Canada Brain Research Fund.
May 3, 2012
SPECT/CT greatly benefits thyroid cancer patients
By AuntMinnie.com staff writers
SPECT/CT changed postsurgical staging in 21% of patients with thyroid cancer, modified the treatment approach in 36% of those with the disease, and helped avoid unnecessary radiation therapy in 20% of patients with no disease in a study in the May issue of the Journal of Nuclear Medicine.
May 2, 2012
Axiom Molecular inks PET supply deal
By AuntMinnie.com staff writers
Australian radiopharmaceutical supplier Axiom Molecular has inked a strategic alliance to conduct PET radiopharmaceutical research, development, and commercialization activities with UniQuest, the University of Queensland's main commercialization company.
May 1, 2012
PET tops SPECT, cardiac MR in diagnosing artery disease
By Wayne Forrest
SPECT, cardiac MR, and PET all reached high sensitivity for detecting obstructive coronary artery disease, but PET turned in the best diagnostic performance in a meta-analysis published in the May 8 edition of the Journal of the American College of Cardiology.
May 1, 2012
Immunomedics lands patent
By AuntMinnie.com staff writers
Biopharmaceutical firm Immunomedics has added another U.S. patent to its intellectual property portfolio.
May 1, 2012
PET/CT locates infection in patients with implantable cardiac devices
By Wayne Forrest
FDG-PET/CT can help differentiate between infection and postoperative inflammation in patients with cardiovascular implantable electronic devices and direct physicians to more appropriate treatment, according to a study published in the May issue of the Journal of the American College of Cardiology.
April 25, 2012
2012 04 26 09 07 36 167 Sarrazin Ied Generator Infection Thumb
GE touts brain PET imaging study results
By AuntMinnie.com staff writers
GE Healthcare touted results from four pooled brain biopsy studies and a brain autopsy study of its investigational PET amyloid imaging agent, F-18 flutemetamol, that confirm the agent's potential to detect beta amyloid plaque, a pathology associated with Alzheimer's disease.
April 25, 2012
Previous Page
Page 299 of 611
Next Page